Sant'Eugenio Hospital is a hospital located in Rome, Italy. It is one of the largest hospitals in Central Italy. The construction of the hospital began in 1933, during the fascist period.

During the past decade, Ospedale S Eugenio conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 16 clinical trials were completed, i.e. on average, 47.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 7 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale S Eugenio" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 17 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 11 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 6 trials sponsored, "Celgene" with 5 trials sponsored and "ETOP IBCSG Partners Foundation" with 5 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale S Eugenio" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 4 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator, "Associazione Nazionale Medici Cardiologi Ospedalieri" with 1 trials as a collaborator, "Augusta University" with 1 trials as a collaborator and "BMR Genomics" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale S Eugenio" are "Leukemia" (18 trials), "Myelodysplastic Syndromes" (8 trials), "Multiple Myeloma" (7 trials), "Acute Myeloid Leukemia" (5 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "Ospedale S Eugenio" in a lesser frequency.

Most popular intervention types in "Ospedale S Eugenio" are "Drug" (64 trials), "Other" (13 trials), "Procedure" (13 trials), "Radiation" (7 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "idarubicin" (9 trials), "Placebo" (8 trials), "cyclophosphamide" (6 trials), "cytarabine" (6 trials) and "etoposide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale S Eugenio" are 80 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale S Eugenio". 1 are not yet recruiting, 11 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Ospedale S Eugenio, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale S Eugenio, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".